DEM Biopharma
dembiopharma.comDem Bio is pioneering the next generation of immunotherapeutics that unleash macrophages and immune phagocytes to eliminate tumors by targeting ‘don’t eat me’ (DEM) and ‘eat me’ (EM) signals on cancer cells and macrophages. Founded by Longwood Fund, it is supported by a syndicate of biotech investors and headquartered in Boston, MA.
Something looks off?Open jobs at DEM Biopharma
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.